Abstract Library

#519 Effectiveness of Transarterial Embolization in Neuroendocrine Tumors

Introduction: Neuroendocrine tumors (NETs) with liver metastases have a poor prognosis. Somatostatin analogues and chemotherapy are used with some success. Transarterial Embolization (TAE) is increasingly used to improve symptom control and reduce tumor size.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Mandair D, Bridgestock H, Mehrzad H, Palmer D, Mangat K,

Keywords: neuroendocrine tumor, Carcinoid, TAE,

#423 Case Report : A Rare Cause of Retroperitoneal Fibrosis Responding to Steroids

Introduction: Retroperitoneal fibrosis is a rare inflammatory disease. Neuroendocrine tumors are a heterogenous group that arise from enterochromaffin cells, most commonly in the gastrointestinal tract. Their capacity to secrete hormones, five HT, tachykinins etc, are responsible for symptoms known as carcinoid syndrome. However NETS, particularly arising from the midgut, can cause fibrosis. This can result in bowel obstruction, but also cause fibrosis in the retroperitoneum, lungs and cardiac valvular fibrosis.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Mandair D, Mangat K, Malaki M, Shah T,

Keywords: neuroendocrine tumor, fibrosis, steroids,

#133 Effectiveness of transarterial embolization of liver neuroendocrine metastases

Introduction: Neuroendocrine tumors (NETs) with diffuse liver metastases have a poor prognosis and prove difficult to palliate. Somatostatin analogues and chemotherapy have been used but often are poorly tolerated and may not provide symptom relief. Transarterial Embolization (TAE) is being increasingly used to improve symptom control and reduce tumor size. We looked at the last 5-year experience of TAE in patients with hepatic metastases from neuroendocrine tumors.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Mandair D, Bridgestock H, Shah T, Mangat K, Oliff S,

Keywords: neuroendocrine tumor, carcinoid syndrome, transarterial embolization, symptom control,